NovaBay Pharmaceuticals (NBY) Assets (2016 - 2025)
Historic Assets for NovaBay Pharmaceuticals (NBY) over the last 17 years, with Q3 2025 value amounting to $3.5 million.
- NovaBay Pharmaceuticals' Assets fell 1005.93% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 1005.93%. This contributed to the annual value of $3.4 million for FY2024, which is 6210.98% down from last year.
- According to the latest figures from Q3 2025, NovaBay Pharmaceuticals' Assets is $3.5 million, which was down 1005.93% from $6.9 million recorded in Q2 2025.
- In the past 5 years, NovaBay Pharmaceuticals' Assets ranged from a high of $24.8 million in Q1 2022 and a low of $3.4 million during Q4 2024
- For the 5-year period, NovaBay Pharmaceuticals' Assets averaged around $12.6 million, with its median value being $12.9 million (2023).
- Its Assets has fluctuated over the past 5 years, first tumbled by 7548.1% in 2024, then surged by 8428.22% in 2025.
- NovaBay Pharmaceuticals' Assets (Quarter) stood at $24.0 million in 2021, then crashed by 31.61% to $16.4 million in 2022, then plummeted by 44.91% to $9.0 million in 2023, then tumbled by 62.11% to $3.4 million in 2024, then grew by 1.87% to $3.5 million in 2025.
- Its Assets stands at $3.5 million for Q3 2025, versus $6.9 million for Q2 2025 and $9.9 million for Q1 2025.